ASX:OSL
OncoSil jumps as trial data puts the FDA pathway back in focus
Small-cap healthcare rallies often begin with a single announcement. OncoSil Medical (ASX:OSL) gave the market three. The pancreatic cancer device…
Newsletter
Sign up for our newsletter and be the first to access our latest articles!
Impressive Mobile First Website Builder
Ready for Core Web Vitals, Support for Elementor, With 1000+ Options Allows to Create Any Imaginable Website. It is the Perfect Choice for Professional Publishers.
OncoSil Medical jumps 27.59% as TRIPP-FFX data puts ASX:OSL back in focus
There are biotech rallies that look like noise. Then there are rallies that arrive with…